Ada Chukwudi has lived with HIV for 10 years. In this interview with Daily Trust, she gave insights into her journey.Tell us a bit about your journey since you were diagnosed with HIV.I was diagnosed ...

South Africa, Eswatini and Zambia on Monday began administering a groundbreaking HIV-prevention injection in the drug's first ...

With cases rising by 3091% since 2010, Fiji is introducing same-day testing and treatment, peer education and support, and ...

You may not realize you’ve benefited from HIV research. But if you’ve received a treatment that was approved through a recent ...

Kamuvudines are a new class of drugs that are derived from the anti-HIV nucleoside reverse transcriptase inhibitors. They are designed to inhibit the inflammasome, part of the innate immune system ...

An oral HIV drug helped patients with center-involved diabetic macular edema achieve improvements in visual acuity, according ...

Pill burden decreases and antiretroviral regimens simplify for many of the participants who start lenacapavir.

The U.S. just shipped two million doses of lenacapavir, a groundbreaking twice-a-year HIV-prevention injectable medication, to the African nations of Eswatini and Zambia, the U.S. State Department ...

Gilead Sciences, Inc. is rated a Buy with robust profitability, solid dividend, prudent M&A and 15-20% upside potential. Read more on GILD stock here.